BLACK PEARL EXTENDS TENDER OFFER FOR ALL OUTSTANDING SHARES OF SELECTIS HEALTH, INC.

Rhea-AI Summary

Selectis Health (OTCQB: GBCS) announced that Black Pearl Equities has extended the expiration of its previously disclosed cash tender offer to purchase all outstanding Selectis common shares at $5.75 per share. The offer, originally set to end at 5:00 p.m. on August 24, 2026, will now expire at 5:00 p.m., New York City time, on August 27, 2026, unless further extended, while conditions to consummate the offer continue to be addressed.

According to Black Pearl, 2,773,036 shares had been validly tendered and not withdrawn as of August 24, 2026. Laurel Hill Advisory Group is the information agent, and Broadridge Corporate Issuer Solutions is acting as depositary for the tender offer.

Positive

• $5.75 per share all-cash tender offer outstanding for Selectis stockholders
• 2,773,036 shares reported validly tendered and not withdrawn as of August 24, 2026
• Tender offer expiration extended to August 27, 2026, giving stockholders additional time to decide

Negative

• Tender offer completion remains subject to unspecified conditions that are still being satisfied
• Offer is only extended through August 27, 2026 and may face further timing uncertainty if not consummated

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, Aug. 25, 2026 /PRNewswire/ -- Black Pearl Equities, a New York-based investment group (together with its affiliates, "Black Pearl"), today announced that it has extended the expiration date of its previously announced tender offer to purchase all of the outstanding shares of common stock of Selectis Health, Inc. (OTCQB: GBCS ) ("Selectis" or the "Company"), a healthcare company, for $5.75 per share in cash.

The tender offer, which was scheduled to expire at 5:00 p.m., New York City time, on August 24, 2026, has been extended and will now expire at 5:00 p.m., New York City time, on August 27, 2026, unless further extended, as the parties continue to work to satisfy certain conditions to the consummation of the offer. All other terms and conditions of the tender offer remain unchanged.

The information agent for the tender is Laurel Hill Advisory Group. Selectis stockholders who need additional copies of the Offer to Purchase, Letter of Transmittal or related materials, or who have questions regarding the tender offer, should contact the information agent toll free at (844) 305-2265 or by email at GBCS@laurelhill.com.

Broadridge Corporate Issuer Solutions, LLC ("Broadridge") is acting as depositary for the tender offer. Broadridge has advised Black Pearl that, as of 5:00 p.m., New York City time, on August 24, 2026, 2,773,036 shares had been validly tendered and not withdrawn from the tender offer.

Important Information

This press release is for informational purposes only and it is neither an offer to purchase nor a solicitation of an offer to sell shares of Selectis' common stock. Black Pearl has filed a Tender Offer Statement on Schedule TO, containing an Offer to Purchase, a form of Letter of Transmittal and other related tender offer documents with the U.S. Securities and Exchange Commission (the "SEC"), and Selectis has filed a Solicitation/Recommendation Statement on Schedule 14D-9 relating to the tender offer with the SEC. Selectis' stockholders are strongly advised to read these tender offer materials carefully and in their entirety as they become available, as they may be amended from time to time, because they contain important information about the tender offer that Selectis' stockholders should consider prior to making any decisions with respect to the tender offer. Once filed, Selectis' stockholders will be able to obtain a free copy of these documents at the website maintained by the SEC at www.sec.gov or by directing a request to the information agent toll free at (844) 305-2265.

Forward-Looking Statements

This press release contains "forward-looking statements". Forward-looking statements can be identified by words like "may," "will," "likely," "should," "expect," "anticipate," "future," "plan," "believe," "intend," "goal," "seek," "estimate," "project," "continue," and variations of such words and similar expressions. These forward-looking statements are not guarantees of future performance and involve risks, assumptions, and uncertainties, including, but not limited to, risks related to: (i) the satisfaction of the conditions to closing the transaction in the anticipated timeframe or at all; (ii) the failure to obtain necessary regulatory approvals; (iii) the ability to realize the anticipated benefits of the transaction; (iv) the ability to successfully integrate the businesses; (v) disruption from the transaction making it more difficult to maintain business and operational relationships; (vi) the negative effects of this announcement or the consummation of the proposed transaction on the market price of Selectis' common stock; (vii) significant transaction costs and unknown liabilities; (viii) litigation or regulatory actions related to the proposed transaction; and (xi) the failure to obtain the necessary financing to complete the transaction. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

The forward-looking statements included in this press release are made only as of the date of this release, and except as otherwise required by federal securities law, neither Selectis nor Black Pearl assumes any obligation nor do they intend to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances.

About Selectis Health, Inc.

Selectis Health, Inc. is a healthcare owner-operator that acquires, develops, and manages skilled nursing facilities, assisted living facilities, and independent living facilities across the South and Southeastern United States. The Company currently operates eight properties in Arkansas and Oklahoma, providing post-acute and skilled nursing care, assisted and independent living services, and continuing care retirement programs, with reimbursement sourced through Medicare, Medicaid, and private pay arrangements. Selectis is focused on delivering quality resident care while pursuing strategic growth opportunities in an expanding senior healthcare market.

Contact

Selectis Health, Inc.
600 17th Street, Suite 2800
Denver, CO 80202

About Black Pearl

Black Pearl is a dynamic investment firm, advisory, and consultancy strategically diversified across healthcare sectors. Headquartered in Brooklyn, New York, Black Pearl fosters strategic synergies and facilitates high-impact transactions.

Contact

Anthony Vitellozzi
Laurel Hill Advisory Group
(844) 305-2265
GBCS@laurelhill.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/black-pearl-extends-tender-offer-for-all-outstanding-shares-of-selectis-health-inc-302858958.html

SOURCE Black Pearl Equities

FAQ

What is Black Pearl’s tender offer for Selectis Health (OTCQB: GBCS) shares in August 2026?

Black Pearl has a cash tender offer to purchase all outstanding Selectis Health shares at $5.75 per share. According to Selectis, this offer targets all common stockholders, providing a specified cash price per share during the stated offer period.

When does the extended tender offer for Selectis Health (GBCS) now expire?

The extended tender offer is scheduled to expire at 5:00 p.m. New York City time on August 27, 2026. According to Black Pearl, this new deadline may be further extended while conditions to consummate the offer continue to be satisfied.

How many Selectis Health (GBCS) shares have been tendered to Black Pearl’s offer so far?

As of 5:00 p.m. on August 24, 2026, 2,773,036 shares had been validly tendered and not withdrawn. According to Black Pearl, this figure reflects shares already submitted into the tender process through the depositary.

Why was the Selectis Health (OTCQB: GBCS) tender offer expiration date extended?

The expiration date was extended so the parties can continue working to satisfy certain conditions required to consummate the offer. According to Black Pearl, all other terms and conditions of the tender offer remain unchanged during this extended period.

Who are the information agent and depositary for the Selectis Health (GBCS) tender offer?

Laurel Hill Advisory Group is the information agent, and Broadridge Corporate Issuer Solutions acts as depositary. According to Black Pearl, Laurel Hill handles stockholder inquiries, while Broadridge receives and holds shares tendered into the offer.

Where can Selectis Health (GBCS) stockholders find the official tender offer documents?

Stockholders can access the Schedule TO, Offer to Purchase, and related documents on the SEC website at www.sec.gov. According to Selectis, copies are also available via the information agent Laurel Hill Advisory Group at its toll-free number.